Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profile

Sagarkumar Patel(National Institute of Pharmaceutical Education and Research), Amit Shard(National Institute of Pharmaceutical Education and Research - Ahmedabad)
European Journal of Pharmaceutical Sciences
December 28, 2021
10.1016/j.ejps.2021.106112
Cited by 39

Related Papers

Emerging therapies and management approaches in sickle cell disease (SCD): A critical review
|Journal of Phytonanotechnology and Pharmaceutical Sciences|2023|9
Simultaneous determiantion of aripiprazole and escitalopram oxalate by HPLC
|Journal of Chemical Metrology|2023|1
IMMUNOGENICITY IN PRECLINICAL DRUG DEVELOPMENT: STRATEGIES, RISKS, AND IMPLICATIONS FOR LARGE MOLECULE-BASED BIOLOGICS INCLUDING CAR T-CELL AND GENE THERAPIES
|Unknown|2023|0